This is the authors' abstract. We don't add key points for this paper.
This Viewpoint compares 2 clinical trials involving immune checkpoint inhibitors in kidney transplant recipients.
No takes yet. Share an insight, caveat, or question.
Stump et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: